vs

Side-by-side financial comparison of Cricut, Inc. (CRCT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Cricut, Inc. is the larger business by last-quarter revenue ($159.5M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). Cricut, Inc. runs the higher net margin — 12.7% vs -38.1%, a 50.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -1.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.6%).

Cricut, Inc. is an American brand of cutting plotters, or computer-controlled cutting machines, designed for home crafters. The machines are used for cutting paper, felt, vinyl, fabric and other materials such as leather, matboard, and wood.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CRCT vs PRCT — Head-to-Head

Bigger by revenue
CRCT
CRCT
1.9× larger
CRCT
$159.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+22.1% gap
PRCT
20.2%
-1.9%
CRCT
Higher net margin
CRCT
CRCT
50.8% more per $
CRCT
12.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-2.6%
CRCT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CRCT
CRCT
PRCT
PRCT
Revenue
$159.5M
$83.1M
Net Profit
$20.3M
$-31.6M
Gross Margin
58.1%
64.9%
Operating Margin
14.4%
-4.1%
Net Margin
12.7%
-38.1%
Revenue YoY
-1.9%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.10
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRCT
CRCT
PRCT
PRCT
Q1 26
$159.5M
$83.1M
Q4 25
$203.6M
$76.4M
Q3 25
$170.4M
$83.3M
Q2 25
$172.1M
$79.2M
Q1 25
$162.6M
$69.2M
Q4 24
$209.3M
$68.2M
Q3 24
$167.9M
$58.4M
Q2 24
$167.9M
$53.4M
Net Profit
CRCT
CRCT
PRCT
PRCT
Q1 26
$20.3M
$-31.6M
Q4 25
$7.8M
$-29.8M
Q3 25
$20.5M
$-21.4M
Q2 25
$24.5M
$-19.6M
Q1 25
$23.9M
$-24.7M
Q4 24
$11.9M
$-18.9M
Q3 24
$11.5M
$-21.0M
Q2 24
$19.8M
$-25.6M
Gross Margin
CRCT
CRCT
PRCT
PRCT
Q1 26
58.1%
64.9%
Q4 25
47.4%
60.6%
Q3 25
55.2%
64.8%
Q2 25
59.0%
65.4%
Q1 25
60.5%
63.9%
Q4 24
44.9%
64.0%
Q3 24
46.1%
63.2%
Q2 24
53.5%
59.0%
Operating Margin
CRCT
CRCT
PRCT
PRCT
Q1 26
14.4%
-4.1%
Q4 25
6.8%
-40.6%
Q3 25
13.3%
-27.8%
Q2 25
17.5%
-28.0%
Q1 25
18.0%
-39.7%
Q4 24
6.6%
-28.9%
Q3 24
6.3%
-38.4%
Q2 24
15.7%
-50.3%
Net Margin
CRCT
CRCT
PRCT
PRCT
Q1 26
12.7%
-38.1%
Q4 25
3.8%
-39.1%
Q3 25
12.0%
-25.7%
Q2 25
14.2%
-24.7%
Q1 25
14.7%
-35.8%
Q4 24
5.7%
-27.6%
Q3 24
6.8%
-35.9%
Q2 24
11.8%
-48.0%
EPS (diluted)
CRCT
CRCT
PRCT
PRCT
Q1 26
$0.10
$-0.56
Q4 25
$0.03
$-0.54
Q3 25
$0.10
$-0.38
Q2 25
$0.11
$-0.35
Q1 25
$0.11
$-0.45
Q4 24
$0.06
$-0.34
Q3 24
$0.05
$-0.40
Q2 24
$0.09
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRCT
CRCT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$236.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$357.5M
$347.7M
Total Assets
$543.8M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRCT
CRCT
PRCT
PRCT
Q1 26
$236.5M
$245.6M
Q4 25
$275.6M
$286.5M
Q3 25
$207.1M
$294.3M
Q2 25
$376.9M
$302.7M
Q1 25
$356.7M
$316.2M
Q4 24
$336.9M
$333.7M
Q3 24
$246.9M
$196.8M
Q2 24
$299.5M
$214.1M
Total Debt
CRCT
CRCT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CRCT
CRCT
PRCT
PRCT
Q1 26
$357.5M
$347.7M
Q4 25
$343.6M
$365.9M
Q3 25
$358.4M
$380.3M
Q2 25
$308.9M
$385.8M
Q1 25
$490.2M
$389.2M
Q4 24
$466.8M
$402.2M
Q3 24
$475.8M
$241.2M
Q2 24
$448.5M
$251.8M
Total Assets
CRCT
CRCT
PRCT
PRCT
Q1 26
$543.8M
$487.1M
Q4 25
$580.8M
$508.1M
Q3 25
$564.3M
$511.5M
Q2 25
$721.5M
$513.1M
Q1 25
$681.7M
$519.4M
Q4 24
$693.0M
$534.0M
Q3 24
$663.8M
$374.1M
Q2 24
$742.1M
$374.4M
Debt / Equity
CRCT
CRCT
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRCT
CRCT

Platform$84.8M53%
Products$74.7M47%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons